Latest news with #iPSCells
NHK
16 hours ago
- Health
- NHK
Facility for producing low-cost iPS cells opens in Osaka
A new center for producing low-cost induced pluripotent stem cells from a patient's own blood has opened in Osaka, western Japan. The Yanai Facility for my iPS Cell Therapy is operated by a foundation affiliated with Kyoto University. Transplanting tissues derived from a patient's own iPS cells is expected to reduce the risk of immune rejection. The cost of production is currently estimated at 50 million yen, or about 350,000 dollars, per batch of cells. The facility aims to reduce the figure to about 1 million yen, or about 6,800 dollars, through automation. The foundation aims to shorten production time from six months to around three weeks, and supply medical institutions with iPS cells for clinical trials starting by fiscal 2028. The facility is equipped with 14 automated iPS cell culture devices and storage rooms. Professor Yamanaka Shinya of Kyoto University, who heads the foundation, says he hopes to provide optimal iPS cells at an affordable price.
Japan Times
04-06-2025
- Business
- Japan Times
Japanese team starts final-stage trial for iPS drug to treat Alzheimer's
A Japanese research team has started a final-stage clinical trial to treat familial Alzheimer's disease patients with a drug discovered through induced pluripotent stem (iPS) cells. This is the first final-stage trial conducted in the field of iPS drug discovery, which uses iPS cells to discover new efficacies of new and existing drugs, the team said Tuesday. The team includes members of Kyoto University's Center for iPS Cell Research and Application (CiRA) and Towa Pharmaceutical, which makes and sells generic drugs.
